Low Vitamin D in Multiple Myeloma: Should You Be Concerned?

Low vitamin D is fairly common in people with multiple myeloma and it can matter because vitamin D helps your body absorb calcium and maintain strong bones. Multiple myeloma itself often weakens bones and raises fracture risk, so being low on vitamin D may add to that risk if it isn’t addressed. Ensuring adequate vitamin D and calcium is a standard part of bone care alongside bone‑strengthening treatments. ^{[1] [2]}

Why vitamin D matters in myeloma

• Multiple myeloma can cause bone damage, pain, and fractures due to tumor activity in the bone marrow. Strong bone support is a key part of care. ^[1]
• Vitamin D helps your gut absorb calcium; without enough vitamin D, you can develop low calcium and weaker bones, especially if you’re also receiving bone‑modifying medicines. ^[2]
• Myeloma and its treatments can also affect kidneys and calcium balance, so clinicians regularly monitor these labs and adjust supplements. ^{[3] [2]}

Standard bone care often includes vitamin D

In many myeloma care plans, bone‑modifying agents such as zoledronic acid or pamidronate are used to reduce skeletal complications; with these, daily vitamin D and calcium are typically recommended unless there’s a reason not to. ^{[4] [5]}

• Typical supportive dosing used with IV bisphosphonates: calcium 500 mg per day plus vitamin D about 400–500 IU per day, adjusted by your clinician. ^{[4] [5]}

What low vitamin D could mean for you

• It may contribute to weaker bones and higher fracture risk when combined with myeloma‑related bone loss. Addressing deficiency can help support bone strength. ^{[1] [2]}
• If you’re on IV bone‑strengthening therapy, low vitamin D increases the chance of hypocalcemia (low blood calcium); keeping vitamin D sufficient helps lower that risk. ^[6]
• Low vitamin D alone does not diagnose, worsen, or predict myeloma activity by itself, but it is one modifiable factor in your overall bone health plan. ^{[1] [2]}

What to do next

• Ask your care team to check your 25‑hydroxy vitamin D level and basic minerals (calcium, magnesium) if not done recently; they may already be monitoring these during treatment. ^[2]
• If you’re deficient, your team will suggest a replacement plan; daily low‑dose (e.g., 400–800 IU) is common for maintenance, while short‑term higher doses may be used to correct deficiency when appropriate. Your exact dose should be personalized based on levels, kidney function, and current therapies. ^[2]
• Keep calcium intake adequate through diet and/or supplements as recommended, and continue fall‑prevention and weight‑bearing activity as you are able to safely. ^[2]

Safety notes and when to be cautious

• If you have high calcium levels from active bone breakdown (hypercalcemia), your team may temporarily limit calcium/vitamin D until calcium stabilizes. Close lab monitoring guides these decisions. ^{[7] [3]}
• Kidney issues are more common in myeloma; dosing of supplements and bone‑modifying drugs is tailored to kidney function, with labs checked before treatments. ^{[3] [5]}
• If you are on bone‑modifying agents, dental checkups and good oral care are advised to lower the rare risk of jaw problems; this is separate from vitamin D but part of overall bone safety. ^[8]

---

Quick reference: Bone health elements in myeloma care

Aspect	Why it matters	Typical approach
Vitamin D sufficiency	Supports calcium absorption and bone strength	Test 25‑OH vitamin D; supplement per level and treatment plan
Calcium adequacy	Maintains bone mineralization; prevents low calcium on therapy	~500 mg/day often used with bone agents, individualized
Bone‑modifying therapy	Reduces fractures and bone pain	Zoledronic acid or pamidronate, with calcium and vitamin D
Lab monitoring	Detects hypercalcemia, hypocalcemia, kidney effects	Periodic calcium, creatinine, and vitamin D checks

^{[4] [5] [2] [6]}

---

Bottom line

• Low vitamin D is common and can add to bone risk in multiple myeloma, but it’s also one of the easiest things to fix. Optimizing vitamin D and calcium under your clinician’s guidance supports bone strength and reduces treatment‑related low calcium risk. ^{[1] [4] [2] [6]}
• You don’t need to panic, but it’s worth addressing promptly with simple testing and tailored supplementation as part of your overall myeloma care plan. ^[2]